ENGINEERED ENZYMES AND METHODS OF MAKING AND USING

The invention provides an engineered carboxylic acid reductase (CAR) enzyme, a nucleic acid encoding the CAR enzyme, and a non-naturally occurring microbial organism comprising an exogenous nucleic acid encoding the CAR, an engineered transaminase (TA) enzyme, and/or a hexamethylenediamine (HMD) tra...

Full description

Saved in:
Bibliographic Details
Main Authors KOMOR, Russell, Scott, ZHANG, Deqiang, GRIFFIN, Benjamin, Matthew, SHAH, Amit, Mahendra, NAGARAJAN, Harish, RICHARDSON, Toby, Howard, WARNER, Joseph, Roy, GHATAK, Sankha
Format Patent
LanguageEnglish
French
German
Published 01.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides an engineered carboxylic acid reductase (CAR) enzyme, a nucleic acid encoding the CAR enzyme, and a non-naturally occurring microbial organism comprising an exogenous nucleic acid encoding the CAR, an engineered transaminase (TA) enzyme, and/or a hexamethylenediamine (HMD) transaminase (TA2) enzyme. The invention provides a non-naturally occurring microbial organism that has a 1,6-hexanediol (HDO) pathway with a HDO pathway enzyme expressed in sufficient amounts to produce 6 aminocaproate semi aldehyde, HDO, or both. The invention further provides a non-naturally occurring microbial organism that has an HMD pathway with a HMD pathway enzyme expressed in sufficient amounts to produce 6-aminocaproate semialdehyde, HMD, or both. The invention additionally provides bioderived HMD, 6-aminocaproate semialdehyde, and/or HDO and methods for producing bioderived HMD, 6-aminocaproate semialdehyde, and/or HDO.
Bibliography:Application Number: EP20210792151